WallStSmart
XNCR

Xencor Inc

NASDAQ: XNCR · HEALTHCARE · BIOTECHNOLOGY

$11.62
-4.36% today

Updated 2026-04-29

Market cap
$861.36M
P/E ratio
P/S ratio
6.86x
EPS (TTM)
$-1.24
Dividend yield
52W range
$7 – $19
Volume
0.9M

Xencor Inc (XNCR) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+50.7%
Last 4 quarters
Revenue YoY growth
-59.7%
Most recent quarter
EPS YoY growth
+85.5%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-4.3%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
-7.9%
2025-08-06
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-04$-0.09+85.1%$12.02$11.16-7.2%
2025-11-05$-0.08+88.4%$13.70$14.00+2.2%
2025-08-06$-0.41+43.1%$7.95$7.32-7.9%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.60$-0.09+85.1%$28.24M-59.7%
2025-09-30$-0.69$-0.08+88.4%$21.00M+18.0%
2025-06-30$-0.72$-0.41+43.1%$43.61M+157.1%
2025-03-31$-0.58$-0.66-13.6%$32.73M+104.6%
2024-12-31$-0.79$-0.62+21.1%$70.02M+37.4%
2024-09-30$-0.98$-0.71+27.6%$17.80M-69.9%
2024-06-30$-0.88$-1.07-21.6%$16.96M-62.7%
2024-03-31$-0.79$-1.11-40.5%$16.00M-15.6%
2023-12-31$-0.09$-0.31-244.4%$50.97M
2023-09-30$-0.73$-0.40+45.2%$59.16M
2023-06-30$-0.80$-0.37+53.8%$45.52M
2023-03-31$-0.66$-1.02-54.5%$18.96M

Frequently asked questions

Has Xencor Inc beaten earnings estimates?
Xencor Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +50.7% over the last 4 quarters.
How does XNCR stock react to earnings?
XNCR stock has moved an average of -4.3% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.
What is Xencor Inc's revenue growth rate?
Xencor Inc reported year-over-year revenue growth of -59.7% in its most recent quarter, with EPS growing +85.5% year-over-year.